Journal of Neurophysiology, Vol 64, Issue 4 1115-1124, Copyright © 1990 by APS

ARTICLES

Electrical stimulation of cervical vagal afferents. II. Central relays for behavioral antinociception and arterial blood pressure decreases

A. Randich, K. Ren and G. F. Gebhart
Department of Psychology, College of Medicine, University of Iowa, Iowa City 52242.

1. Supraspinal substrates mediating vagal afferent stimulation (VAS)-induced inhibition of the nociceptive tail-flick reflex were examined by the use of the soma-selective neurotoxin ibotenic acid and the nonselective local anesthetic lidocaine. Fifty rats were studied in the lightly anesthetized state maintained with pentobarbital sodium. 2. The threshold intensity of VAS required to inhibit the tail-flick reflex to a cut-off latency of 10 s was established in all rats. Ibotenic acid (5 or 10 micrograms, 0.5 microliter) or lidocaine (4%, 0.5 microliter) was then microinjected into various regions of the brain stem followed by reestablishment of the intensity of VAS required to produce inhibition of the tail-flick reflex. 3. Microinjections of ibotenic acid into the ipsilateral nucleus tractus solitarius (NTS), medial rostroventral medulla (principally the nucleus raphe magnus; NRM), or bilaterally into the dorsolateral pons (principally the locus coeruleus/subcoeruleus; LC/SC), significantly increased the threshold intensity of VAS required to inhibit the tail-flick reflex. Microinjections of ibotenic acid into either the rostral or caudal ventrolateral medulla (RVLM or CVLM, respectively) ipsilateral to the vagus nerve stimulated or ipsilateral LC/SC did not significantly affect the inhibition produced by VAS. Arterial blood pressure decreases produced by VAS were significantly attenuated or eliminated after microinjections of ibotenic acid into the NTS, RVLM, CVLM, or NRM. Lidocaine microinjected into the ipsilateral CVLM also significantly increased the intensity of VAS required to inhibit the tail-flick reflex. 4. These outcomes obtained with behavioral measures are consistent with the outcomes of the preceding study using electrophysiological measures in establishing that cells in the NTS, LC/SC, and NRM regions and fibers of passage in the CVLM are important in mediating the inhibitory effects of VAS. The present studies confirm previous reports of the importance of the RVLM and CVLM in VAS-produced depressor responses but also demonstrate that the NRM is critical for this cardiovascular response.

This article has been cited by other articles:

				X. Ding, J. L. Ardell, F. Hua, R. J. McAuley, K. Sutherly, J. J Daniel, and C. A. Williams Modulation of cardiac ischemia-sensitive afferent neuron signaling by preemptive C2 spinal cord stimulation: effect on substance P release from rat spinal cord Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R93 - R101. [Abstract] [Full Text] [PDF]

				D. Budai, S. G. Khasabov, P. W. Mantyh, and D. A. Simone NK-1 Receptors Modulate the Excitability of ON Cells in the Rostral Ventromedial Medulla J Neurophysiol, February 1, 2007; 97(2): 1388 - 1395. [Abstract] [Full Text] [PDF]

				F. Hua, J. L. Ardell, and C. A. Williams Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1468 - R1477. [Abstract] [Full Text] [PDF]

				A. Kirchner, F. Birklein, H. Stefan, and H. O. Handwerker Left vagus nerve stimulation suppresses experimentally induced pain Neurology, October 24, 2000; 55(8): 1167 - 1171. [Abstract] [Full Text] [PDF]

				G Holtmann, J Gschossmann, J Neufang-Huber, G Gerken, and N J Talley Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls Gut, September 1, 2000; 47(3): 332 - 336. [Abstract] [Full Text] [PDF]

				L. Guasti, P. Grimoldi, A. Diolisi, M. R. Petrozzino, G. Gaudio, A. M. Grandi, M. G. Rossi, and A. Venco Treatment With Enalapril Modifies the Pain Perception Pattern in Hypertensive Patients Hypertension, May 1, 1998; 31(5): 1146 - 1150. [Abstract] [Full Text] [PDF]

				S. Ghione Hypertension-Associated Hypalgesia: Evidence in Experimental Animals and Humans, Pathophysiological Mechanisms, and Potential Clinical Consequences Hypertension, September 1, 1996; 28(3): 494 - 504. [Abstract] [Full Text]